Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Type

Type

Guidance programme

Advice programme

Showing 1 to 33 of 33

TitleReference numberPublishedLast updated
Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetesIPG787
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetesTA943
Tirzepatide for treating type 2 diabetesTA924
Diabetes (type 1 and type 2) in children and young people: diagnosis and managementNG18
Finerenone for treating chronic kidney disease in type 2 diabetesTA877
Type 1 diabetes in adultsQS208
Type 2 diabetes in adultsQS209
Diabetes in pregnancyQS109
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetesMIB312
Type 1 diabetes in adults: diagnosis and managementNG17
Type 2 diabetes in adults: managementNG28
Diabetes in children and young peopleQS125
d-Nav insulin management app for type 2 diabetesMIB285
Diabetes in pregnancy: management from preconception to the postnatal periodNG3
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetesMIB227
Sotagliflozin with insulin for treating type 1 diabetesTA622
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
Type 2 diabetes: prevention in people at high riskPH38
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetesTA390
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetesMIB51
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar)ESNM64
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo)ESNM65
Type 2 diabetes: insulin degludec/liraglutide (Xultophy)ESNM60
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Canagliflozin in combination therapy for treating type 2 diabetesTA315
Type 2 diabetes: insulin degludecESNM25
Type 2 diabetes prevention: population and community-level interventionsPH35
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitusTA151
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitusIPG257

Results per page

  1. 10
  2. 25
  3. 50
  4. All